WT1 and mesothelioma: The University Hospital of Antwerp has started a similar protocol in mesothelioma and several other solid tumours but is using WT-1 as antigen loading for the DCs (ClinicalTrials.gov Identifier: NCT01291420), circumventing the need for patient's tumour material.